Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial
Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial
Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose
Higher-valent pneumococcal vaccines for children. Information for the Health Council of the Netherlands
Effect of seven-valent pneumococcal conjugate vaccine on staphylococcus aureus colonisation in a randomised controlled trial
Immunogenicity of a hexavalent vaccine co-administered with 7-valent pneumococcal conjugate vaccine: findings from the national immunization program in the Netherlands
Immune and strain surveillance of the Streptococcus pneumoniae: tools to study the impact of pneumococcal conjugate vaccination
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid